Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Slate360 Provides Valuable Insights on the Advantages of Working with a Skilled Healthcare Event Marketing Agency
Via Prodigy
Exposures Product Safety
APPLIED THERAPEUTICS Investors Are Encouraged to Contact Kaplan Fox &amp; Kilsheimer LLP Regarding Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers APLT
APPLIED THERAPEUTICS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Exposures Product Safety
Tickers APLT
After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For Bladder Cancer
Via Benzinga
Exposures Product Safety
Tickers AZN DSKYF DSNKY
420 with CNW — FDA OKs Study Exploring Marijuana Use for Treating PTSD in Veterans
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
Southbridge, MA Veteran & Author Publishes Memoir
Via PR Leap
Topics Product Recall
Exposures Legal Product Safety
Merus Scores Its First FDA Approval For Lung Cancer Drug
Via Benzinga
Exposures Product Safety
Tickers MRUS
Nano X Imaging Jumps To 4-Month High On FDA Green Light For X-Ray System: Retail In Frenzy
Via Stocktwits
Exposures Product Safety
Nano-X Imaging Shares Are Rising Thursday: Here's Why
Via Benzinga
Exposures Product Safety
Tickers NNOX
FDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung Cancer
Via Benzinga
Exposures Product Safety
Tickers AZN
Kaplan Fox &amp; Kilsheimer LLP is Investigating Potential Securities Law Violations Against Applied Therapeutics, Inc. (APLT)
Via TheNewswire.com
Exposures Product Safety
Tickers APLT
2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick
Via MarketBeat
Topics Government Lawsuit
Exposures Financial Legal Political
Tickers HIMS LLY NVO TDOC
Say Hello World Inc. Unveils ‘Say Hello’ App to Revolutionize Social Connections
Via AB Newswire
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
Tickers CI
420 with CNW — FDA OKs Study Exploring Marijuana Use for Treating PTSD in Veterans
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis Product Safety
Tickers SNDL
Kaplan Fox &amp; Kilsheimer LLP is Investigating Applied Therapeutics, Inc. (APLT) for Potential Securities Law Violations
Via TheNewswire.com
Exposures Product Safety
Tickers APLT
Breaking Free from Recurrent C. diff, a Serious Gut Infection
Via Brandpoint
Topics Product Recall
Exposures Legal Product Safety
Why This Cannabis Company Recalled Over 3,000 Gummies In Missouri
Via Benzinga
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
'Never Thought I'd Be A Person To Have a Nervous Breakdown' – Elon Musk Recalls Christmas Of 2008 'Everything Was Going Wrong At Once'
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Expands Leadership Team to Support TNX-102 SL Launch
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
New Crime Novel Explores Tragedy, Mystery, And Resilience Against All Odds
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Actuated Medical Secures FDA 510(k) Clearance for GripTract-GI™ Endoscopic Tissue Manipulator, a Major Advancement in GI Procedural Innovation
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch
Via Benzinga
Exposures Product Safety
Tickers BTI MO TPB
NVIDIA Invested in These 2 AI Stocks, Should You?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers EXAI MGA NVDA OUST
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
Via Newsfile
Exposures Product Safety
Tickers ELTP
FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy
Via Benzinga
Exposures Product Safety
Tickers BLUE
Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application
Via Benzinga
Exposures Product Safety
Tickers APLT
Orthopedic Surgeon Dr. Robert MacArthur Opens Up On His Early Career and Education in New Online Interview
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Via MarketBeat
Topics Government
Exposures COVID-19 Political Product Safety
Tickers AZN HIMS LLY PFE
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
Via Benzinga
Exposures Product Safety
Tickers CABA
2 Generic Drug Stocks Ready to Surge in 2025
Via MarketBeat
Topics Government Intellectual Property
Exposures Intellectual Property Political Product Safety
Tickers AMGN LXRX PFE TEVA
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.